Special Issue "Diabetic Retinopathy"
A special issue of International Journal of Translational Medicine (ISSN 2673-8937).
Deadline for manuscript submissions: 31 October 2021.
Interests: disease burden; pathogenesis/treatments for AMD; other retinal diseases (clinical and laboratory)
Diabetic retinopathy (DR) is a common cause of visual loss across the world, especially in the working-age group. As the prevalence of diabetes mellitus (DM) continues to increase worldwide, the occurrence of DR and diabetic macular oedema (DMO) continues to climb. The risks for DR and DR are known, and our understanding of the underlying pathophysiology has advanced recently. The introduction of pharmacologic therapies, and modern diagnostic modalities of optical coherence tomography (OCT) and more recently, OCT angiography (OCT-A) has resulted in better management and outcomes for DR, with vision preservation in some patients. However, early detection of DR remains crucial in achieving early treatment and better visual outcomes.
This Special Issue aims to provide updated information, including reviews, original clinical and laboratory studies, population studies, development of new tools, disease detection, and service delivery in DR and diabetic care from across the different continents.
Prof. Dr. Winfried Amoaku
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Translational Medicine is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Diabetic retinopathy (DR)
- Diabetic macular oedema
- DR understanding
- DR clinical management
- DR screening/detection
- DR service delivery
- DR visual impairment